MAPT and Alzheimer disease: When [11C]PBB3 PET was performed in a patient with corticobasal degeneration, tracer retention was noted in the neocortical and subcortical structures, while [11C]PIB uptake was normal, highlighting the potential of tau tracers in non-AD tauopathies [58].